All filters
Slidesets
The Impact of COVID-19 on Hepatitis Elimination (Health Care Perspective) - Saeed Hamid
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
Reduction of Hepatitis C Burden in Islamabad, Pakistan Slums Through CHW Screen and Treat Programs - Hassan Mahmood
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
Update on Hepatitis Delta Therapy - Robert Gish MD, FAASLD, AGAF, FAST
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Update on New Antiviral Targets –non –Capsid Inhibitors - Man-Fung YuenMBBS, MD, PhD, DSc
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Update on New Immuno Modulators - Adam Gehring PhD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Update on Novel Combination Strategies - Marion Peters MD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Update on New Antiviral Targets Core Capsid Inhibitors (CpAMs) - Kosh Agarwal BMedSci (Hons) MD FRCP
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Safety Monitoring for Investigational HBV Drugs and Discontinuation of HBV Therapy - Poonam Mishra MD, MPH, FAASLD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Toxicity in new and established HBV compounds - Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2020
Slidesets
How to interpret flares in HBV trials with novel agents - Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Rationale for including immune tolerant and low viral load patients in new drug trials placeholder - Henry Lik Yeun Chan
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Potential of new combinations to achieve functional cure for Chronic Hepatitis B - Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Managing Highly Treatment-Experienced Patients - Prof. Anca Streinu Cercel -
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
The Acute HCV Epidemic in MSM: What Have We Learned Thus Far? Christoph Boesecke
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
ART in Women: Which Drugs are Safe and What are the Challenges? - Dr. Annette Haberl
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
STI Diagnostics in the CEE Region - Pawel Jakubowski
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
2020: Have We Reached the 90-90-90 Targets? - Teymur Noori
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
HIV and COVID-19 co-infection: An update Cristiana Oprea
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
PrEP Implementation in the CEE Region: What are the Successes, What are the Barriers? Prof. Milosz Parczewski
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
Debate: Do Integrase Inhibitors and/or TAF Lead to Weight Gain? Con Standpoint - Jürgen Rockstroh
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
Long-Acting Therapies: Which Patients Will Benefit Most? - Dr. Sharon Walmsley
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
Gilleece, Yvonne - The Management of Hepatitis in Pregnancy
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020